Stockscreener 앱 받기
2.07
6.15%
0.12
시간 외 거래:
2.07
Advanced Biomed Inc 주식(ADVB)의 최신 뉴스
Financing Quarterly Statistics, Q1 2025 - insights.citeline.com
Biomedical Engineering Courses: Admission 2025, Fees, Eligibility, Entrance Exams, Syllabus/Subjects, Top Colleges, Career Scope & Salary - Shiksha
Harbour BioMed Reports Full Year 2024 Financial Results - Yahoo Finance
Mainz enrols first subject in study to evaluate colorectal cancer test - Yahoo Finance
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study - Yahoo Finance
Advanced Instruments to Acquire and Merge with Nova Biomedical - Contract Pharma
Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generation Obesity Therapies - PR Newswire
Advanced Biomed Inc. Completes Successful IPO Launch - TipRanks
Revolutionizing Biomedical Research: Unveiling the Power of Microphysiological Systems with Advanced Assays, Integrated Sensor Technologies, and Real-Time Monitoring - ACS Publications
Why Checkpoint Therapeutics Shares Are Trading Higher By Around 66%; Here Are 20 Stocks Moving Premarket - Benzinga
Red-hot market supports two med-tech IPOs in a day - BioWorld Online
A Dynamic Duo: Travis Stancil and Natella Devitskya Celebrate Five Years of Captivating Performances - The Manila Times
Advanced Biomed Inc. Announces Closing of Initial Public Offering Raising $6.56 Million - Nasdaq
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering - Morningstar
Advanced Biomed prices IPO at $4 per share - MSN
Advanced Biomed Prices 1.6 Million Shares to Raise $6.6 Million in IPO - MarketScreener
OverDrive Appoints Eric Miller to Lead the Company's Data and Information Science Services - The Manila Times
ADVB IPO NewsTaiwanese diagnostics developer Advanced Biomed prices downsized US IPO at the $4 low end - Renaissance Capital
Advanced Biomed Inc. Announces Pricing of Initial Public Offering - GlobeNewswire
This Cancer Detection Biotech Just Priced Its Nasdaq IPOKey Details Inside - StockTitan
Can Mainz Biomed's 82% Detection Rate Technology Revolutionize Colorectal Cancer Prevention? - StockTitan
IPO Roundup: Advanced Biomed, Brag House Holdings and more - MSN
HBM Alpha Therapeutics Enters Strategic Collaboration and License Agreement to Advance Novel Endocrine Therapies - BioSpace
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development - PR Newswire
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development - GlobeNewswire
Mainz Biomed Initiates U.S. Clinical Study to Evaluate Performance of Next Generation Test on Advanced Adenomas over Large Patient Population - Yahoo Finance
Moderna Secures $590M Funding From U.S. Government for Bird Flu Jab - Yahoo Finance
NVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and Healthcare - NVIDIA Newsroom
Anaconda Biomed Appoints Trent Reutiman New CEO - Business Wire
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead Magazine
Mainz Biomed Enters Agreement with Quest Diagnostics to Advance ColoAlert Colorectal Cancer Screening Test - Nasdaq
Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms - Business Wire
Advanced Biomedical Material Design to Toxicity - ResearchGate
Mainz Biomed Announces Reverse Stock Split Soon After Collaborating With MedTech Giant Thermo Fisher Scientific - Benzinga
Thermo Fisher Scientific and Mainz Biomed Partner to Advance Colorectal Cancer Screening Technology - citybuzz -
Mainz Biomed Partners with Thermo Fisher to Advance Colorectal Cancer Screening - Contract Pharma
Shire Plans San Diego Campus - Site Selection Magazine
L&K BIOMED Announces FDA Approval of the BluEX Lumbar Expandable Cage System, Featuring Advanced Surface Technology for Comprehensive Spine Interbody Fusion Options. - Becker's Spine Review
Advanced Biomed dramatically downsizes proposed IPO to $9.4M - MSN
Taiwanese diagnostics developer Advanced Biomed slashes deal size by 92% ahead of $9 million US IPO - renaissancecapital.com
Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update - Yahoo Finance
Thermoelectric Materials and Devices for Advanced Biomedical ApplicationsJia2024Small - Wiley Online Library
Iron‐MOFs for Biomedical ApplicationsYu2025Advanced Healthcare Materials - Wiley Online Library
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors - PR Newswire
Roche and BARDA: partnering for better brain health - Roche
AskBio and Belief BioMed partner to advance gene therapies - Pharmaceutical Technology
AskBio to collaborate with Belief BioMed to explore the potential of new gene therapies - Bayer
Curi Bio’s Growth Propels Move to Prime Seattle Location to Advance Cutting-Edge Drug Discovery Research - Business Wire
(PDF) Polysaccharide-Based Hydrogels for Advanced Biomedical Engineering Applications - ResearchGate
Polysaccharide-Based Hydrogels for Advanced Biomedical Engineering Applications - ACS Publications
Medical Device Maker Nova Biomedical Is Exploring a Sale - BNN Bloomberg
Genexys BioMed Awarded $320K SBIR Grant to Advance Novel Cystic Fibrosis Gene Therapy - PR Newswire
Biomedical applications of functional hydrogels: Innovative developments, relevant clinical trials and advanced products - ScienceDirect.com
Mainz BioMed Seeks FDA Breakthrough Device Designation for Advanced Colorectal Cancer Test - Proactive financial news
Mainz Biomed seeks FDA’s Breakthrough Devices Designation for advanced colorectal cancer test - News-Medical.Net
NASDAQ – Stock Price, Charts and News Today - BNN Bloomberg
Mainz Biomed Announces Submission for FDA Breakthrough Device Designation for its Next Generation CRC Screening Test - Yahoo Finance
Advanced Melanoma Clinical Trial Pipeline Analysis - GlobeNewswire
Leading Medical Centers in Taiwan Adopt NVIDIA Accelerated Computing to Advance Biomedical Research - NVIDIA Blog
German company acquires Allentown-based Bio Med Science - Lehigh Valley Business
Harnessing stimuli‐responsive biomaterials for advanced biomedical applicationsLiao2025Exploration - Wiley Online Library
0.34%
0.46%
자본화:
|
볼륨(24시간):